T/CHATA 022-2022 Active Group standards

T/CHATA 022-2022 The diagnosis and management principles for drug-induced liver injury caused by anti-tuberculosis drugs

T/CHATA 022-2022 The diagnosis and management principles for drug-induced liver injury caused by anti-tuberculosis drugs

Publish Date: 2022-09-09 Implement Date: 2022-09-09 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 34.00
Out of stock

Basic Information

Standard Code: T/CHATA 022-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Health
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2022-09-09
Implement Date: 2022-09-09
Pages: 16 pages

Scope

This document stipulates the diagnostic criteria, diagnosis, and treatment principles for drug-induced liver injury caused by anti-tuberculosis drugs in tuberculosis patients without underlying liver diseases.
This document is applicable to all levels and types of medical and health institutions and their medical staff across the country in the diagnosis and treatment of drug-induced liver injury caused by anti-tuberculosis drugs.

Development Information

Word Count: 27 Thousand words Pages: 16 pages

Related Standards

Contact Us